Nita McEvoy
CEO & Lead Trainer Revive NX UK & Ireland
Nita McEvoy is the Founder and Lead Educator of Revive NX Ltd, delivering advanced regenerative aesthetic training through the Longevity Institute. Her work centres on structural restoration, collagen stimulation and undetectable injectable techniques grounded in biological longevity.
Nita developed the 5-Step Revive Rejuvenation Roadmap, a structured regenerative journey that has become the benchmark global process adopted by CHA Meditech for protocol-led integration and longevity-focused aesthetic practice.
Recognised internationally for her contribution to regenerative aesthetics, Nita has received global industry recognition and has chaired regenerative forums at IMCAS Paris, contributing to high-level discussions on biotechnology, safety and long-term aesthetic outcomes.
Through Revive NX Ltd, she educates practitioners in regenerative protocols, clinical precision and commercially sustainable business models, helping them build confident, future-ready aesthetic practices rooted in structure, integrity and measurable results.
Practitioners are invited to join our national Revive NX roadshow events across the UK and Ireland, where you can train with Nita in person, experience hands-on regenerative education and gain the tools to build a successful, forward-thinking clinic.
Integrated Training Support
FREE Online CPD Training (Worth £229)
With your first box purchase of Revive NX Exosomes (5 sets) – £360.
This structured online programme supports safe clinical integration, regenerative protocol development and confident, profitable implementation within your practice.
Your training access includes future updates as biotechnology evolves, ensuring your knowledge remains aligned with current advancements and best practice standards.
Please note: This is not a treatment modality qualification. Practitioners must already be trained and competent in microneedling in order to use exosomes and undertake this CPD training
Our Exosome Skin Rejuvenation training is directly aligned with the Research, Development and Education teams at CHA Meditech, part of the CHA Bio Group, ensuring practitioners receive laboratory-informed protocols and clinically current guidance.
Through close collaboration between our CEO and the CHA Meditech leadership and scientific teams, Revive NX delivers up-to-date regenerative protocols, structured treatment pathways and instructional support that reflect the latest advancements in biotechnology.
This ensures our professionals integrate exosomes with clarity, safety, and confidence.